A Study of HS-20122 in Patients With Advanced Solid Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is a first-in-human (FIH) Phase I, multi-center, open-label, study of HS-20122, in patients with advanced solid tumors. This study will evaluate the safety, tolerability, pharmacokinetics and efficacy of HS-20122 in advanced solid tumors.
Epistemonikos ID: ae09d226b0b4a0b57b26747d9424888e9e31f662
First added on: Apr 16, 2025